Sharda Cropchem Limited
NSE:SHARDACROP.NS
545.45 (INR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 31,630.245 | 40,451.566 | 35,757.02 | 23,912.317 | 19,981.554 | 19,955.49 | 17,067.655 | 13,903.188 | 12,185.798 | 10,610.647 | 7,903.726 | 7,781.02 |
| Cost of Revenue
| 26,519.521 | 28,607.829 | 24,998.091 | 16,359.559 | 13,887.514 | 13,875.885 | 11,437.448 | 8,973.693 | 7,922.746 | 7,100.666 | 5,140.408 | 5,442.93 |
| Gross Profit
| 5,110.724 | 11,843.737 | 10,758.929 | 7,552.758 | 6,094.04 | 6,079.605 | 5,630.207 | 4,929.495 | 4,263.052 | 3,509.981 | 2,763.318 | 2,338.09 |
| Gross Profit Ratio
| 0.162 | 0.293 | 0.301 | 0.316 | 0.305 | 0.305 | 0.33 | 0.355 | 0.35 | 0.331 | 0.35 | 0.3 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 2,879.536 | 2,309.712 | 1,792.161 | 1,649.48 | 1,177.419 | 1,106.334 | 849.574 | 730.366 | 542.662 | 516.021 | 430.044 | 0 |
| Selling & Marketing Expenses
| 1,000.164 | 1,051.33 | 713.81 | 516.643 | 417.648 | 405.947 | 474.079 | 454.622 | 384.924 | 409.273 | 325.174 | 0 |
| SG&A
| 4,954.994 | 3,361.042 | 2,505.971 | 2,166.123 | 1,595.067 | 1,512.281 | 1,323.653 | 1,184.988 | 927.586 | 925.294 | 755.218 | 135.85 |
| Other Expenses
| -4,357.372 | 402.805 | 12.605 | 22.78 | 25.838 | 92.696 | 37.614 | 14.499 | 28.197 | 33.205 | 11.149 | 0 |
| Operating Expenses
| 4,954.994 | 7,317.901 | 5,637.173 | 4,270.961 | 3,571.574 | 3,218.574 | 2,652.06 | 2,247.353 | 1,837.969 | 1,711.633 | 1,424.633 | 1,179.65 |
| Operating Income
| 155.73 | 4,783.135 | 4,837.528 | 2,878.513 | 2,135.058 | 2,695.475 | 2,978.147 | 2,682.142 | 2,425.083 | 1,798.348 | 1,338.685 | 1,036.26 |
| Operating Income Ratio
| 0.005 | 0.118 | 0.135 | 0.12 | 0.107 | 0.135 | 0.174 | 0.193 | 0.199 | 0.169 | 0.169 | 0.133 |
| Total Other Income Expenses Net
| 562.986 | -475.687 | -195.141 | 216.032 | -286.365 | -345.225 | -106.252 | 35.376 | 165.254 | -39.739 | 229.196 | 141.54 |
| Income Before Tax
| 718.716 | 4,307.448 | 4,642.387 | 3,094.545 | 1,848.693 | 2,350.25 | 2,871.895 | 2,717.518 | 2,590.337 | 1,758.609 | 1,567.881 | 1,177.8 |
| Income Before Tax Ratio
| 0.023 | 0.106 | 0.13 | 0.129 | 0.093 | 0.118 | 0.168 | 0.195 | 0.213 | 0.166 | 0.198 | 0.151 |
| Income Tax Expense
| 399.654 | 887.621 | 1,149.613 | 802.368 | 201.776 | 586.817 | 964.164 | 813.874 | 834.962 | 524.336 | 443.192 | 334.44 |
| Net Income
| 318.831 | 3,419.594 | 3,492.535 | 2,291.741 | 1,646.624 | 1,763.43 | 1,907.652 | 1,904.386 | 1,749.703 | 1,229.712 | 1,110.517 | 843.73 |
| Net Income Ratio
| 0.01 | 0.085 | 0.098 | 0.096 | 0.082 | 0.088 | 0.112 | 0.137 | 0.144 | 0.116 | 0.141 | 0.108 |
| EPS
| 3.53 | 37.9 | 38.71 | 25.4 | 18.25 | 19.55 | 21.14 | 21.11 | 19.41 | 13.63 | 12.31 | 9.35 |
| EPS Diluted
| 3.53 | 37.9 | 38.71 | 25.4 | 18.25 | 19.55 | 21.14 | 21.11 | 19.41 | 13.63 | 12.31 | 9.35 |
| EBITDA
| 2,827.048 | 6,833.722 | 7,355.416 | 5,150.573 | 3,717.185 | 3,828.849 | 3,713.14 | 3,209.024 | 2,832.426 | 1,816.757 | 1,784.377 | 1,403.58 |
| EBITDA Ratio
| 0.089 | 0.169 | 0.206 | 0.215 | 0.186 | 0.192 | 0.218 | 0.231 | 0.232 | 0.171 | 0.226 | 0.18 |